Sen. Cory Booker @SenBooker
While typically terminally ill patients are allowed to access drugs that are in FDA clinical trials, they are barred from accessing Schedule I drugs, despite their therapeutic potential. https://t.co/VdNxjoBqX1 — PolitiTweet.org